Every 8-K that National Healthcare Corp. (NHC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHC filings page.
National HealthCare Corporation declared a quarterly cash dividend of $0.67 per common share, payable on October 30, 2026 to shareholders of record as of September 30, 2026. The company communicated this action through a press release referenced in the current report.
As of August 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,323 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 775 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies, along with additional post-acute and support services. The release includes customary forward-looking statement cautions referencing regulatory, operational, and reimbursement risks.
National HealthCare Corporation reported stronger results for the quarter ended June 30, 2026. Net operating revenues were $408,025,000 compared with $374,910,000 a year earlier, an 8.8% increase, driven primarily by the June 1, 2026 acquisition of five skilled nursing facilities with 639 licensed beds in Tennessee and South Carolina.
GAAP net income attributable to NHC was $40,319,000 versus $23,722,000 in the prior-year quarter, with GAAP diluted EPS of $2.54 versus $1.52. Excluding unrealized gains on marketable equity securities and other non-GAAP adjustments, adjusted net income was $27,551,000 versus $25,710,000, a 7.2% increase, and adjusted diluted EPS was $1.74 versus $1.65. For the first six months of 2026, net operating revenues totaled $789,846,000 and GAAP diluted EPS was $4.82.
On the balance sheet as of June 30, 2026, total assets were $1,536,930,000, NHC stockholders’ equity was $1,122,302,000, and current and long-term debt was eliminated compared with $40,000,000 at December 31, 2025. The quarterly dividend declared per common share was $0.67, up from $0.64 a year earlier.
National HealthCare Corporation completed a major real estate transaction by acquiring from National Health Investors the land and buildings for 32 skilled nursing facilities and three independent living facilities it had long leased, for a $560 million cash purchase price.
The company funded the deal with borrowings under its new Credit Agreement, drawing $475 million from a senior unsecured term loan and $55 million from its senior unsecured revolving credit facility, plus cash on hand. It simultaneously increased the revolver capacity from $50 million to $75 million and terminated commitments under a prior 2024 credit facility that had no outstanding borrowings.
A Partial Master Lease Termination Agreement ended the master lease for all acquired facilities except four Florida skilled nursing facilities, where a third-party operator’s lease continues and the master lease for those properties was assigned to an NHC subsidiary. NHC states that owning these properties, located across seven states, aligns with its strategy and is expected to be accretive to earnings, cash flow, and long-term investor returns.
National HealthCare Corporation entered into a new Credit Agreement providing a $475.0 million senior unsecured term loan and a $50.0 million senior unsecured revolving credit facility. The term loan is intended to finance part of the purchase price for NHC’s previously announced acquisition of assets and real property from National Health Investors and affiliates.
The company expects to draw the full $475.0 million term loan, and may draw on the revolver at closing, currently anticipated on or around July 1, 2026, in the third quarter of 2026. The facilities mature five years after initial funding, with the term loan amortizing in quarterly installments of about $5.9 million and the revolver requiring interest-only payments.
Interest is based on Term SOFR or a base rate plus a margin that varies with NHC’s consolidated leverage ratio, initially set at Term SOFR + 1.50% or base rate + 0.50%. The agreement replaces NHC’s existing undrawn credit facility and includes customary financial covenants, events of default, and lender remedies. Commitments terminate automatically if the transaction is not completed or funded by August 31, 2026.
National HealthCare Corporation entered into a Purchase and Sale Agreement for its subsidiary NHC/OP, L.P. to acquire the land, buildings, and related assets of a portfolio of five skilled nursing facilities from National Health Corporation for $50.5 million, subject to adjustments. The facilities are already managed by NHC affiliates, and existing management agreements will terminate at closing. The buyer will post a $750,000 refundable deposit during an inspection period ending by June 16, 2026, and establish a $2.0 million escrow fund for 12 months after closing to cover indemnity claims. Closing is expected in the second quarter of 2026 but depends on financing, regulatory approvals to transfer operating licenses, and other conditions, and either party may terminate if the transaction is not completed within nine months after June 1, 2026.
National HealthCare Corporation reported the results of its Annual Meeting of Shareholders held on May 7, 2026. Shareholders owning 12,216,578 shares of Common Stock were present in person or by proxy, out of 15,599,046 shares outstanding as of the March 13, 2026 record date, so a quorum was established.
Shareholders re-elected Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams as directors for three-year terms. For example, Hassan received 11,653,122 votes for, 544,934 against, and 18,522 abstentions. Shareholders also approved, on an advisory basis, the compensation of the Named Executive Officers, with 11,964,538 votes for, 233,276 against, and 18,764 abstentions.
National HealthCare Corporation reported higher first quarter 2026 results. Net operating revenues for the quarter ended March 31, 2026 were $381.8 million, up from $373.7 million a year earlier, an increase of 2.2%.
GAAP net income attributable to NHC rose to $35.9 million from $32.2 million, while adjusted net income increased to $30.1 million from $24.8 million, a 21.1% gain. GAAP diluted EPS were $2.27 versus $2.07, and adjusted diluted EPS were $1.91 versus $1.59.
Cash, cash equivalents and marketable securities totaled $258.4 million at March 31, 2026, and current and long‑term debt were reduced to $0 from $40.0 million at December 31, 2025. The quarterly dividend per share increased to $0.64 from $0.61, supported by steady skilled nursing volumes and higher average per‑diem rates.
National HealthCare Corporation declared a higher quarterly cash dividend, signaling a modest boost in shareholder returns. The company will pay a quarterly dividend of $0.67 per common share to shareholders of record on June 30, 2026, with payment on July 31, 2026. This dividend represents a 4.7% increase over the prior quarter’s regular common dividend, indicating steady, incremental growth in its cash distributions.
As of May 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,323 beds, along with assisted and independent living communities, behavioral health hospitals, homecare and hospice agencies, and related services such as pharmacy and rehabilitation. The company also highlights typical healthcare industry risks and includes standard forward-looking statement cautions.
National HealthCare Corporation agreed to buy the real estate of 32 skilled nursing facilities and three independent living facilities it currently leases from National Health Investors for $560 million. The assets span seven states and will shift NHC from tenant to owner for most locations.
NHC will fund the purchase partly through a new credit facility and must place a $5 million initial deposit, followed by an additional $15 million deposit if it proceeds after a due‑diligence review period ending by May 29, 2026. NHI will post a $20 million liquidated damages deposit that NHC can claim in certain seller default scenarios.
The transaction is expected to close in the third quarter of 2026, subject to customary conditions, including Hart‑Scott‑Rodino clearance. The existing master lease will be terminated for most facilities at closing, but four Florida skilled nursing facilities will remain leased to a third‑party operator under an assigned master lease.
National HealthCare Corporation reported strong 2025 results, with net operating revenues and grant income of $1,517,781,000 versus $1,307,382,000 in 2024, a 16.1% increase driven by higher same‑facility revenue and the White Oak acquisition.
GAAP net income attributable to NHC rose to $120,015,000 from $101,927,000, while adjusted net income increased to $104,067,000 from $76,862,000, a 35.4% gain. GAAP diluted EPS were $7.67 versus $6.53, and adjusted diluted EPS were $6.65 versus $4.93.
In the fourth quarter, GAAP net income attributable to NHC was $24,849,000 versus $6,081,000 a year earlier, and adjusted net income was $28,774,000 versus $25,954,000, up 10.9%. NHC also reduced current and long‑term debt to $40,000,000 from $137,000,000 and increased stockholders’ equity to $1,068,772,000.
National HealthCare Corporation expanded its Board of Directors from seven to nine members effective February 12, 2026, appointing Dr. David Gifford and Andrew Adams as independent directors. Gifford joins as a Class 2 Director, expected to stand for a three‑year term at the 2027 annual meeting. Adams joins as a Class 1 Director and will be nominated for a three‑year term at the 2026 annual meeting.
Dr. Gifford brings long experience in geriatrics, public health leadership and long‑term care policy, while Adams contributes prior NHC facility administration experience and current leadership of a multilocation financial services business. Gifford will serve on the Nominating and Corporate Governance Committee and Adams on the Compensation Committee, and both will receive NHC’s standard non‑employee director compensation and indemnification.
National HealthCare Corporation announced a regular quarterly cash dividend of $0.64 per common share. The dividend will be paid to shareholders of record on March 31, 2026, with payment scheduled for April 30, 2026, reinforcing its ongoing cash return to shareholders.
As of February 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,329 beds, 26 assisted living communities with 1,413 units, and nine independent living communities with 777 units, along with behavioral health hospitals, homecare, hospice, pharmacy, and rehabilitation services.
National HealthCare Corporation announced board and leadership updates. On November 6, 2025, the Board appointed Dr. Lisa Piercey as a Class 1 independent director and named her to the Audit Committee. She will be a nominee for a three‑year term at the 2026 Annual Meeting and will receive standard non‑employee director compensation. She will also enter into the company’s standard director and officer indemnification agreement.
The company confirmed succession steps tied to the previously announced retirement of President and COO R. Michael Ussery effective December 31, 2025. CEO Stephen F. Flatt will also serve as President upon Mr. Ussery’s retirement, with no compensation changes approved at this time. Timothy J. Shelly, SVP Operations, will assume the role of principal operating officer following the retirement. A press release regarding the new director was furnished as Exhibit 99.1.
National HealthCare Corporation (NHC) filed an 8-K under “Other Events” disclosing that the company issued a press release on November 6, 2025 announcing its quarterly common dividend. The press release is furnished as Exhibit 99.1 and incorporated by reference.
The filing also notes that NHC’s common stock trades on the NYSE American under the symbol NHC. Investors can review dividend specifics in the attached Exhibit 99.1.
National HealthCare Corporation (NHC) furnished an 8-K to announce it issued a press release covering its earnings for the period ended September 30, 2025. The full press release is provided as Exhibit 99.1, with the cover page Inline XBRL embedded as Exhibit 104. NHC’s common stock trades on the NYSE American under the symbol NHC.
National Healthcare Corporation (NHC) disclosed that R. Michael Ussery, its President and Chief Operating Officer, informed the company on September 23, 2025 that he will retire effective December 31, 2025. Mr. Ussery has been with NHC since 1980 and has held roles including Senior Vice President-Operations, Senior Vice President-Central Region, Regional Vice President and multiple facility Administrator positions; he was named Administrator of the Year in 1989. He became Chief Operating Officer on January 1, 2009 and was appointed President on January 1, 2017, and will continue serving in both roles through his retirement. The company furnished a press release dated September 26, 2025 as Exhibit 99.1.
National HealthCare Corporation's tenant subsidiary has been notified by its landlord, National Health Investors, Inc., of alleged non-compliance with four non-monetary provisions of a Master Lease covering 35 facilities. The landlord's September 8, 2025 letter asserts a default and invoked the lease cure provisions, giving the tenant thirty days to cure or risk an Event of Default. The tenant disputes that the alleged matters constitute defaults, says it has proceeded with reasonable diligence to address any issues, and is negotiating with the landlord. The Master Lease currently runs through December 31, 2026, with two five-year renewal options and a right of first refusal to purchase leased properties; termination that removes renewal rights could have a material adverse effect on NHC's financial condition.
National HealthCare Corporation filed a current report to disclose that it issued a press release on August 8, 2025 announcing its earnings for the period ended June 30, 2025. The company states that the full earnings press release is provided as Exhibit 99.1 and is incorporated by reference, meaning the detailed financial results and commentary are contained in that attached document rather than in this summary filing.
National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.